Original Story: Ubisoft has announced today that Assassin's Creed Unity is getting a free next-gen upgrade to 60FPS (frames per-second) on Xbox Series X and Xbox Series S this Thursday, March 5th.

Unity Software U is slated to release its fourth-quarter 2025 results on Feb. 11, 2026. For the fourth quarter, revenues are expected in the range of $480-$490 million. The Zacks Consensus Estimate ...

Unity Software (U) plunged 25% on Wednesday after the gaming development platform reported its fourth quarter 2025 financial results and outlook. Although the fourth quarter results topped estimates, ...

Feb 11 (Reuters) - Shares of videogame engine maker Unity Software (U.N), opens new tab dropped nearly 30% on Wednesday after the company forecast first-quarter revenue below Wall Street expectations, ...

Unity reports fourth-quarter results that "comfortably exceeded" its high-end guidance, including a boost in its Create Solutions and Grow Solutions revenue by 8% and 11%, respectively. Overall ...

Yahes provided first quarter 2026 guidance of total revenues between $480 million and $490 million and adjusted EBITDA of $105 million to $110 million. Grow segment is forecast to be flat sequentially ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

Lee Hallman is a freelance writer for credit cards and travel rewards at Forbes Advisor. She is a source of information and inspiration for readers looking to navigate the world of travel with savvy ...

A multicurrency account lets you spend and hold different currencies to make managing life or work abroad easier. Many, or all, of the products featured on this page are from our advertising partners ...

EquityMultiple is a real estate crowdfunding platform that gives investors access to professionally managed commercial real estate. The lowest investment minimum is $5,000, but investors must be ...

Cognitive scores improve in 60% of patients with relapsing-remitting MS and remain stable in another 28% after 3 years of treatment with ozanimod, a new study shows.